The Navilas® Retina Laser Makes Microsecond Pulsing Treatment Predictable and Reproducible – Software Release 3.4

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

New Website Informs Diabetics about the Navigated Laser Treatment of Vision-Threatening Retinal Diseases

The new internet platform www.navilas.com informs diabetics and their relatives comprehensively...

Experiences from a Retina Practice in Hawaii: Managing a Special Patient Population

Dr. Marc Tafoya runs a retina specialty practice in Waipahu, Hawaii. In this interview, he explains...

JOS 2018 Symposium "Navigation Laser along with OCT-Angiography"

Secure last-minute spot in Osaka, Japan

This week, our partner Acura will host a special symposium on navigated laser therapy at the The...

OD-OS Software Update for Navilas® 577+ and Navilas® 532 Benefits Long-Term Customers

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

Shortening the Laser Photocoagulation Learning Curve With a Navigated System

Mastering this can be challenging for residents, but a navigated laser helps expedite training.

Laser photocoagulation has long been used as a first-line treatment for DME, yet several studies...

Key Trends Impacting Retinal Laser Care in 2018

Where is retinal laser care heading in 2018? We have looked at results on “Preferences and Trends...

Dr. Lars Freisberg of Tulsa Retina Consultants Shares His Experience of Utilizing the Navilas Retina Laser System in a Private Practice.

In this interview, Dr. Freisberg explains how Navilas contributes to better time management in his ...

David M. Brown, MD, Talks About the Navilas Retina Laser and his Take Home Message from TREX-DME

At AAO 2017, OD-OS talked to David M. Brown, MD, of Retina Consultants Houston about his experiences...

At AAO 2017, OD-OS Announces New Framework for Remote Planning of Navigated Retinal Laser Treatments

NaviGATE opens up new possibilities of digital collaboration, transparency and standardization in...

At AAO 2017: How Tissue-Friendly Retinal Laser Treatment Can Be Approached with Navilas 577s

Tissue-friendly laser treatment with lower powered laser pulses or a train of extremely short...

OD-OS releases major software update for Navilas 577s

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

OD-OS launches Pre-Planned PRP for its Navilas Laser System

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

Compact Navilas® Laser System 577s Receives U.S. FDA Clearance

Introduction of a compact Navilas Laser System to bring the benefits of navigated retina laser into day-to-day clinical routine

OD-OS, the global leader in the development and commercialization of navigated laser...

Navilas® Laser System 577+ Receives U.S. FDA Clearance

OD-OS, the world leader in Navigated Retinal Imaging and Laser Treatment, today announced the...

OD-OS presents novel Yellow 577nm Navilas Laser System with microsecond pulsing option at World Ophthalmic Congress in Tokyo

OD-OS, the world leader in navigated laser therapy for retinal disease management, announced today...

Multicenter Study Announced to Evaluate Novel Combination Therapy for Treatment of Diabetic Macular Edema

TREX-DME Trial to Validate Efficacy and Stability of Treatment with Navilas® Navigated Laser plus Ranibizumab

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...

Navilas® Navigated Laser Plus anti-VEGF Combination Therapy for Diabetic Macular Edema Shown to Reduce Retreatment Rates by More Than 50% While Stabilizing Visual Acuity

Study Shows Novel Combination Treatment Superior to Anti-VEGF Therapy Alone

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...

Learn how to make navigated laser work for you

Contact the Navilas® team